[Preclinical pharmacological profiles and clinical outcome of the novel melatonin-receptor agonist ramelteon (Rozerem 8 mg)]

Nihon Yakurigaku Zasshi. 2010 Jul;136(1):51-60. doi: 10.1254/fpj.136.51.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Chronic Disease
  • Cyclic AMP / metabolism
  • Drug Evaluation, Preclinical
  • Humans
  • Indenes / administration & dosage*
  • Indenes / adverse effects
  • Indenes / pharmacology
  • Randomized Controlled Trials as Topic
  • Receptors, Melatonin / agonists*
  • Sleep Initiation and Maintenance Disorders / drug therapy*
  • Sleep Stages / drug effects
  • Substance-Related Disorders
  • Suprachiasmatic Nucleus / drug effects
  • Suprachiasmatic Nucleus / physiology

Substances

  • Indenes
  • Receptors, Melatonin
  • ramelteon
  • Cyclic AMP